Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Key Senate Panel Struggles To Reach Consensus
"The Senate Finance Committee, which is seeking a bipartisan compromise, has failed to reach an agreement" on health care reform, Bloomberg reports, "even as two House committees and a Senate panel cleared their versions of the legislation with only Democratic approval." The open-ended question of when, and what, the Finance panel will propose, has become the focus of Senators and the administration as the August recess nears with no deal in sight. Max Baucus, D-Mont., the Finance chairman, said a deal could come this week "at the earliest," a month after he originally planed to finalize a version of the bill, Bloomberg reports (Litvan and Jensen, 7/20).

Bovie Medical Corporation Announces FDA Submission Of Laparoscopic Device For Solid Organ Resection
Bovie Medical Corporation (the "Company") (NYSE-AMEX Symbol: BVX), a manufacturer and marketer of electrosurgical products, announced a 510K submission to the FDA seeking pre-market clearance for a laparoscopic SEER device for solid organ resection. The laparoscopic SEER is a line extension of the Saline Enhance Electrosurgical Resection (SEER) device that Bovie launched earlier this year and will address the growing market of minimally invasive liver resection.
News of the day
CEL-SCI Files Patent Application To Support Company's Treatment For More Virulent Strain Of H1N1 Swine And Other Influenza Viruses
CEL-SCI CORPORATION (NYSE AMEX: CVM) announced that it has filed a provisional U.S. patent application covering its L.E.A.P.S.(TM) immune therapy drugs (vaccines) for the prevention/treatment of H1N1, swine, bird flu, Influenza A and/or evolving mutants or variants of these viruses. Some experts believe that by the next flu season the swine flu virus will have evolved and/or combined with other viruses to create a much more lethal new virus. That is what happened in the case of the Spanish flu pandemic. CEL-SCI"s efforts to fight this virus are focused on using conserved epitopes from essential proteins to be found in the A influenza virus for H1N1, H1N5, swine, bird flu and Spanish influenza to create an effective vaccine/treatment that could potentially fight such a mutant virus.
Cardiovascular

British Medical Association Cymru Wales Launches The 'Option 7' Campaign - To Improve The Lives Of Junior Doctors

BMA Cymru Wales on Monday launched a campaign aimed at improving the working lives of junior doctors in Wales. The doctors" trade union has become increasingly concerned about working conditions of junior doctors and the impact that this could have both on careers and on patient safety. This includes; *Lack of training opportunities *Unsafe staffing levels *Bullying/ intimidation *Non-compliant rota/ rota gaps *Insufficient locum cover Junior doctors are understandably afraid to voice any concerns themselves with senior management, for fear of repercussions. That is why BMA Cymru Wales is launching the Option 7 campaign - named after the option on a BMA phone line that juniors can select, to discuss bullying and harassment in confidence. The on-going campaign will involve BMA Welsh secretary Dr Richard Lewis and BMA Welsh council chairman Dr Andrew Dearden meeting with the chairs and chief executives of the new NHS health boards in Wales. Dr Dearden says: "We are hearing of some worrying cases concerning junior doctors, which seem to be more widespread than just "one-off" incidents. It has got to the point where it is starting to affect the reputation of training in Wales. It will also further adversely affect the recruitment and retention of junior doctors in Wales, which it is probably fair to say, is at a critical point now. "Those who raise concerns are afraid of retribution and retaliation, and we decided we could no longer deal with these on a one-to-one basis, that there was a very real need for a dedicated campaign by BMA Cymru Wales, on behalf of junior doctors. "It is vitally important that we get the message out there that this type of behaviour cannot and will not be tolerated, no matter what the , either from management or clinical staff. In the meetings with NHS health board managers (chief executives and chairs), BMA Cymru Wales will be offering support to employers to resolve the problems highlighted and drawing up an action plan together, with the involvement of the Wales Deanery, to include; *What exactly will be done to address the issues *Who will take responsibility for making sure action is taken *Setting deadlines for action and resolving problems raised in these meetings Dr Lewis and Dr Dearden will also be meeting as many junior doctors as possible during the campaign. Dr David Samuel, Chairman of the BMA"s Welsh junior doctors committee thinks some of the issues are much more far-reaching: "I think we are just scratching the surface at the moment of what could prove to be an endemic situation. "We understand that trusts have to meet targets and have gaps to fill on the rotas, but the training and welfare of juniors are also important." The Option 7 campaign also has a facebook presence with groups set up for juniors and their families and friends to show their support for the campaign. For more information, visit www.bma.org.uk View Dr Andrew Dearden and Dr David Samuel talking about the Option 7 Campaign on BMA Cymru TV on YouTube, follow the link below; http://www.youtube.com/watch?v=fQSYSDT8wRc&feature=channel_page The British Medical Association.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009